Chinese researchers have developed a new stem cell therapy for Parkinson’s disease which reportedly provides rapid ...
Parkinson’s disease currently affects nearly one million Americans with no specific known cause and no cure. Treatments have come a long way over the past few decades focusing on managing symptoms and ...
Most cell surface proteins did not. But 16 did, including two found in the human dopamine neurons of the substantia nigra, a ...
The first healthy volunteers have been dosed in an early clinical trial testing NRG5051, a disease-modifying therapy for ALS ...
An estimated 1.1 million Americans are living with Parkinson’s disease (PD), making it the second most common neurodegenerative disease after Alzheimer’s. “Parkinson’s is a disease in which neurons ...
A major scientific revelation has ignited fresh optimism for the millions of people living with Parkinson’s disease worldwide. Researchers have successfully decoded the structure and activation ...
Northwestern Medicine scientists have discovered that targeting neuronal signaling controlling aberrant learning in the ...
Parkinson's disease is no longer viewed as a faraway neurological ailment buried in textbooks. More than 10 million people ...
2don MSN
Scientists report new immune insights and targets into LRRK2 mutations in Parkinson's disease
Parkinson's disease (PD) is a debilitating and progressive neurodegenerative disorder caused by the loss of ...
SynuSight Biotech has licensed (18) F-FD4 to XingImaging and to ABLi Therapeutics to evaluate alpha-synuclein clearance from the brain in response to risvodetinib treatment ...
An estimated 1.1 million Americans are living with Parkinson’s disease (PD), making it the second most common neurodegenerative disease after Alzheimer’s. “Parkinson’s is a disease in which neurons ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback